Letters

Partnership between NHS and pharmaceutical sector is needed

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7291.930 (Published 14 April 2001) Cite this as: BMJ 2001;322:930
  1. Tadataka Yamada, research and development chairman (Patricia_Quinn-1@sbphrd.com)
  1. SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex CM19 5AW

    EDITOR—Smith's news item reported my concerns on the declining status of the NHS as a location for clinical trials conducted by pharmaceutical companies, and was clear and accurate.1 Smith drew on material compiled by the research and development directorate of the NHS Executive, and I welcome their recognition of industry's issues and concerns. Moreover, I applaud the focus of the Clinical Research Working Group of the Pharmaceutical Industry Competitiveness Task Force, a joint initiative of government and industry that is seeking solutions for these …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe